Baird analyst Whit Mayo said yesterday's 12% selloff in Universal Health following the publication by BuzzFeed of an investigative piece on the company's behavioral health business seems overdone, as little "new" content emerged in the report and the majority of incidents occurred years ago in facilities that are known to be under investigation. Universal's response "seems thoughtful" and sufficiently answers the author's accusations, added Mayo, who keeps an Outperform rating and $132 price target on the stock.
Barclays analyst Andrew Mok raised the firm's price target on Universal Health to $189 from $181 and keeps an Equal Weight rating on the shares post the Q1 report. The company posted broad pricing strength and strong acute inpatient volumes, which drove a big EBITDA beat, the analyst tells investors in a research note.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here